FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011525> ?p ?o ?g. }

• W4377011525 endingPage "182" @default.
• W4377011525 startingPage "171" @default.
• W4377011525 abstract "Abstract Purpose This study aimed to examine the clinical characteristics and outcomes of patients with estrogen receptor-negative (ER−)/progesterone receptor-positive (PR+) early breast cancer. We also aimed to investigate the benefits of adjuvant endocrine therapy (ET) in this patient population. Methods Patients with early breast cancer diagnosed at West China Hospital were divided into the ER−/PR+, ER+, and ER−/PR− groups. The chi-square test was used to analyze differences in clinical and pathological features among the groups. Multivariable Cox and Fine–Gray regression models were used to compare mortality and locoregional recurrence (LRR)/distant recurrence (DR), respectively. We performed a subgroup analysis to determine which ER−/PR+ patients can benefit more from ET. Results From 2008 to 2020, we enrolled 443, 7104, and 2892 patients into the ER−/PR+, ER+, and ER−/PR− groups, respectively. The ER−/PR+ group showed more unfavorable clinical features and aggressive pathological characteristics than the ER+ group. The mortality, LRR, and DR rates were higher in the ER−/PR+ than in the ER+ group. Most clinical features and pathological characteristics were similar between the ER−/PR+ and ER−/PR− group and their outcomes were comparable. In the ER−/PR+ group, patients who received ET showed significantly lower LRR and mortality rates than those who did not; however, no difference was observed in DR. Subgroup analysis suggested that ER−/PR+ patients age ≥ 55 years, and postmenopausal status can benefit from ET. Conclusion ER−/PR+ tumors have more aggressive pathological characteristics and more unfavorable clinical features than ER+ tumors. ET can reduce the LRR and mortality rates in ER−/PR+ patients. Postmenopausal and age ≥ 55 years ER−/PR+ patients can benefit from ET." @default.
• W4377011525 created "2023-05-19" @default.
• W4377011525 creator A5005215310 @default.
• W4377011525 creator A5036867616 @default.
• W4377011525 creator A5039557924 @default.
• W4377011525 creator A5054927824 @default.
• W4377011525 creator A5075584064 @default.
• W4377011525 creator A5079594267 @default.
• W4377011525 creator A5085323694 @default.
• W4377011525 date "2023-05-18" @default.
• W4377011525 modified "2023-10-14" @default.
• W4377011525 title "A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer" @default.
• W4377011525 cites W1565755321 @default.
• W4377011525 cites W1811094195 @default.
• W4377011525 cites W1811830995 @default.
• W4377011525 cites W1881540319 @default.
• W4377011525 cites W1974026856 @default.
• W4377011525 cites W2000536166 @default.
• W4377011525 cites W2012870865 @default.
• W4377011525 cites W2014135194 @default.
• W4377011525 cites W2016510957 @default.
• W4377011525 cites W2017238868 @default.
• W4377011525 cites W2018351534 @default.
• W4377011525 cites W2030134660 @default.
• W4377011525 cites W2044702943 @default.
• W4377011525 cites W2065346432 @default.
• W4377011525 cites W2092495956 @default.
• W4377011525 cites W2103652553 @default.
• W4377011525 cites W2107412392 @default.
• W4377011525 cites W2115705183 @default.
• W4377011525 cites W2118728607 @default.
• W4377011525 cites W2128347157 @default.
• W4377011525 cites W2128832860 @default.
• W4377011525 cites W2131308508 @default.
• W4377011525 cites W2131964282 @default.
• W4377011525 cites W2147043875 @default.
• W4377011525 cites W2165432902 @default.
• W4377011525 cites W2166970215 @default.
• W4377011525 cites W2169676280 @default.
• W4377011525 cites W2193620385 @default.
• W4377011525 cites W2288763477 @default.
• W4377011525 cites W2329942918 @default.
• W4377011525 cites W2803725301 @default.
• W4377011525 cites W2997147953 @default.
• W4377011525 cites W2999400187 @default.
• W4377011525 cites W3173362574 @default.
• W4377011525 cites W3194058693 @default.
• W4377011525 cites W4205399187 @default.
• W4377011525 cites W4221104751 @default.
• W4377011525 cites W4283219245 @default.
• W4377011525 doi "https://doi.org/10.1007/s10549-023-06964-6" @default.
• W4377011525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37199804" @default.
• W4377011525 hasPublicationYear "2023" @default.
• W4377011525 type Work @default.
• W4377011525 citedByCount "0" @default.
• W4377011525 crossrefType "journal-article" @default.
• W4377011525 hasAuthorship W4377011525A5005215310 @default.
• W4377011525 hasAuthorship W4377011525A5036867616 @default.
• W4377011525 hasAuthorship W4377011525A5039557924 @default.
• W4377011525 hasAuthorship W4377011525A5054927824 @default.
• W4377011525 hasAuthorship W4377011525A5075584064 @default.
• W4377011525 hasAuthorship W4377011525A5079594267 @default.
• W4377011525 hasAuthorship W4377011525A5085323694 @default.
• W4377011525 hasBestOaLocation W43770115251 @default.
• W4377011525 hasConcept C121608353 @default.
• W4377011525 hasConcept C126322002 @default.
• W4377011525 hasConcept C143998085 @default.
• W4377011525 hasConcept C188816634 @default.
• W4377011525 hasConcept C207886595 @default.
• W4377011525 hasConcept C2777164284 @default.
• W4377011525 hasConcept C2908647359 @default.
• W4377011525 hasConcept C29456083 @default.
• W4377011525 hasConcept C50382708 @default.
• W4377011525 hasConcept C530470458 @default.
• W4377011525 hasConcept C71924100 @default.
• W4377011525 hasConcept C84606932 @default.
• W4377011525 hasConcept C90924648 @default.
• W4377011525 hasConcept C98717036 @default.
• W4377011525 hasConcept C99454951 @default.
• W4377011525 hasConceptScore W4377011525C121608353 @default.
• W4377011525 hasConceptScore W4377011525C126322002 @default.
• W4377011525 hasConceptScore W4377011525C143998085 @default.
• W4377011525 hasConceptScore W4377011525C188816634 @default.
• W4377011525 hasConceptScore W4377011525C207886595 @default.
• W4377011525 hasConceptScore W4377011525C2777164284 @default.
• W4377011525 hasConceptScore W4377011525C2908647359 @default.
• W4377011525 hasConceptScore W4377011525C29456083 @default.
• W4377011525 hasConceptScore W4377011525C50382708 @default.
• W4377011525 hasConceptScore W4377011525C530470458 @default.
• W4377011525 hasConceptScore W4377011525C71924100 @default.
• W4377011525 hasConceptScore W4377011525C84606932 @default.
• W4377011525 hasConceptScore W4377011525C90924648 @default.
• W4377011525 hasConceptScore W4377011525C98717036 @default.
• W4377011525 hasConceptScore W4377011525C99454951 @default.
• W4377011525 hasFunder F4320333335 @default.
• W4377011525 hasIssue "2" @default.
• W4377011525 hasLocation W43770115251 @default.
• W4377011525 hasLocation W43770115252 @default.

• next